The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Paul J. Martin

Division of Clinical Research

Department of Medicine

Fred Hutchinson Cancer Research Center

University of Washington

USA

[email]@fhcrc.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Clinical Research, Department of Medicine, Fred Hutchinson Cancer Research Center, University of Washington, USA. 1998 - 2010
  • Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA. 2009
  • Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, Washington 98109-1024, France. 2006

References

  1. Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. Martin, P.J., Counts, G.W., Appelbaum, F.R., Lee, S.J., Sanders, J.E., Deeg, H.J., Flowers, M.E., Syrjala, K.L., Hansen, J.A., Storb, R.F., Storer, B.E. J. Clin. Oncol. (2010) [Pubmed]
  2. Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease. Martin, P.J., Storer, B.E., Rowley, S.D., Flowers, M.E., Lee, S.J., Carpenter, P.A., Wingard, J.R., Shaughnessy, P.J., DeVetten, M.P., Jagasia, M., Fay, J.W., van Besien, K., Gupta, V., Kitko, C., Johnston, L.J., Maziarz, R.T., Arora, M., Jacobson, P.A., Weisdorf, D. Blood (2009) [Pubmed]
  3. Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement. Martin, P.J., Bachier, C.R., Klingemann, H.G., McCarthy, P.L., Szabolcs, P., Uberti, J.P., Schuster, M.W., Weisdorf, D., Chao, N.J., Kebriaei, P., Shpall, E.J., Macmillan, M.L., Soiffer, R.J. Biol. Blood Marrow Transplant. (2009) [Pubmed]
  4. Biology and management of chronic graft-versus-host disease. Martin, P.J., Pavletic, S.Z. Cancer Treat. Res. (2009) [Pubmed]
  5. Biology of chronic graft-versus-host disease: implications for a future therapeutic approach. Martin, P.J. Keio. J. Med (2008) [Pubmed]
  6. Study design and endpoints in graft-versus-host disease. Martin, P.J. Best. Pract. Res. Clin. Haematol (2008) [Pubmed]
  7. Pitfalls in the design of clinical trials for prevention or treatment of acute graft-versus-host disease. Martin, P.J., Nash, R.A. Biol. Blood Marrow Transplant. (2006) [Pubmed]
  8. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report. Martin, P.J., Weisdorf, D., Przepiorka, D., Hirschfeld, S., Farrell, A., Rizzo, J.D., Foley, R., Socie, G., Carter, S., Couriel, D., Schultz, K.R., Flowers, M.E., Filipovich, A.H., Saliba, R., Vogelsang, G.B., Pavletic, S.Z., Lee, S.J. Biol. Blood Marrow Transplant. (2006) [Pubmed]
  9. Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation. Martin, P.J., McDonald, G.B., Sanders, J.E., Anasetti, C., Appelbaum, F.R., Deeg, H.J., Nash, R.A., Petersdorf, E.W., Hansen, J.A., Storb, R. Biol. Blood Marrow Transplant. (2004) [Pubmed]
  10. Diagnosis and clinical management of chronic graft-versus-host disease. Martin, P.J., Carpenter, P.A., Sanders, J.E., Flowers, M.E. Int. J. Hematol. (2004) [Pubmed]
  11. Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation. Martin, P.J., Pei, J., Gooley, T., Anasetti, C., Appelbaum, F.R., Deeg, J., Hansen, J.A., Nash, R.A., Petersdorf, E.W., Storb, R., Ghetie, V., Schindler, J., Vitetta, E.S. Biol. Blood Marrow Transplant. (2004) [Pubmed]
  12. A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients. Martin, P.J., Rowley, S.D., Anasetti, C., Chauncey, T.R., Gooley, T., Petersdorf, E.W., van Burik, J.A., Flowers, M.E., Storb, R., Appelbaum, F.R., Hansen, J.A. Blood (1999) [Pubmed]
  13. Involvement of donor T-cell cytotoxic effector mechanisms in preventing allogeneic marrow graft rejection. Martin, P.J., Akatsuka, Y., Hahne, M., Sale, G. Blood (1998) [Pubmed]
 
WikiGenes - Universities